[
    [
        {
            "time": "2021-Q1",
            "original_text": "医药板块基金持仓报告：医药板块持仓环比提升",
            "features": {
                "keywords": [
                    "医药板块",
                    "基金持仓",
                    "环比提升"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "医药板块基金持仓报告：医药板块持仓环比提升",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021",
            "original_text": "去年业绩大涨，检测巨头今年将面临“不合理医疗检查”大考",
            "features": {
                "keywords": [
                    "业绩大涨",
                    "检测巨头",
                    "不合理医疗检查"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "去年业绩大涨，检测巨头今年将面临“不合理医疗检查”大考",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021",
            "original_text": "医药生物行业跨市场周报：小阳春行情渐入佳境 核心资产与二三线齐发力",
            "features": {
                "keywords": [
                    "医药生物",
                    "小阳春行情",
                    "核心资产",
                    "二三线"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业跨市场周报：小阳春行情渐入佳境 核心资产与二三线齐发力",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021",
            "original_text": "热景生物问鼎A股“业绩王” 千倍增长是否昙花一现？",
            "features": {
                "keywords": [
                    "热景生物",
                    "业绩王",
                    "千倍增长"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "热景生物问鼎A股“业绩王” 千倍增长是否昙花一现？",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021",
            "original_text": "华鑫证券给予安图生物推荐评级，装机量显着增加，业绩逐步恢复",
            "features": {
                "keywords": [
                    "华鑫证券",
                    "安图生物",
                    "推荐评级",
                    "装机量增加",
                    "业绩恢复"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华鑫证券给予安图生物推荐评级，装机量显着增加，业绩逐步恢复",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021",
            "original_text": "热景生物业绩飙涨超1000倍，体外诊断化身“风口上的猪”？",
            "features": {
                "keywords": [
                    "热景生物",
                    "业绩飙涨",
                    "体外诊断",
                    "风口"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "热景生物业绩飙涨超1000倍，体外诊断化身“风口上的猪”？",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021",
            "original_text": "安图生物(603658)：收入端持续边际改善 看好公司IVD平台化长期优势",
            "features": {
                "keywords": [
                    "安图生物",
                    "收入端改善",
                    "IVD平台化",
                    "长期优势"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安图生物(603658)：收入端持续边际改善 看好公司IVD平台化长期优势",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021",
            "original_text": "安图生物(603658)：疫情影响逐步消除 流水线装机加速",
            "features": {
                "keywords": [
                    "安图生物",
                    "疫情影响",
                    "流水线装机",
                    "加速"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安图生物(603658)：疫情影响逐步消除 流水线装机加速",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021",
            "original_text": "八大券商主题策略：深度挖掘疫苗产业链机会 核心资产标的名单曝光",
            "features": {
                "keywords": [
                    "券商",
                    "疫苗产业链",
                    "核心资产",
                    "标的名单"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "八大券商主题策略：深度挖掘疫苗产业链机会 核心资产标的名单曝光",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021",
            "original_text": "生物医药行业周报：医用同位素中长期发展规划发布 政策春风推动核医学提速",
            "features": {
                "keywords": [
                    "生物医药",
                    "医用同位素",
                    "规划发布",
                    "政策春风",
                    "核医学"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物医药行业周报：医用同位素中长期发展规划发布 政策春风推动核医学提速",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021",
            "original_text": "对话国金医疗首席袁维：医疗板块两个关键的投资机会不可错过！",
            "features": {
                "keywords": [
                    "国金医疗",
                    "袁维",
                    "医疗板块",
                    "投资机会"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "对话国金医疗首席袁维：医疗板块两个关键的投资机会不可错过！",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]